(Q37216292)
Statements
1 reference
Phase I/II trial of weekly bortezomib with lenalidomide and dexamethasone in first relapse or primary refractory myeloma (English)
1 reference
Pieter Sonneveld
1 reference
Henk Lokhorst
1 reference
Annemiek Broijl
1 reference
Marie-José Kersten
1 reference
Wendimagegn Ghidey Alemayehu
1 reference
Mark-David Levin
1 reference
Okke de Weerdt
1 reference
Edo Vellenga
1 reference
Ellen Meijer
1 reference
Shulamit Wittebol
1 reference
Bea C Tanis
1 reference
Petra B Cornelisse
1 reference
Marian Stevens-Kroef
1 reference
Gerard M J Bos
1 reference
Pierre W Wijermans
1 reference
11 December 2015
1 reference
1 reference
e149-52
1 reference
Identifiers
1 reference
1 reference
1 reference